VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 701–800 of 1,013
Microvascular Repair: Post‐Angiogenesis Vascular Dynamics
LeBlanc, A. J., Krishnan, L., SULLIVAN, C. J., Williams, S. K., & Hoying, J. B. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00207.x · Cited by 67
“Subsequent work has identified a number of molecular programs involved in AV specification including the Ephrin ⁄ Eph, Notch, and VEGF signaling axes [74,176,213].”
BackgroundGelfand, M. V., Hong, S., & Gu, C. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.01.001 · Cited by 60
“For further discussion of VEGF signaling, see Ref. [ 77 ] and Box 2.”
BackgroundJNK-Dependent Stat3 Phosphorylation Contributes to Akt Activation in Response to Arsenic Exposure
Liu, J., Chen, B., Lu, Y.-M., Guan, Y., & Chen, F. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs199 · Cited by 67
“(Olsson et al., 2006).”
Yan, X., Managlia, E. Z., Liu, S. X. L., Tan, X., Wang, X., Marek, C., & Plaen, I. G. D. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00273.2015 · Cited by 65
Briasoulis, Α., Tousoulis, D., Antoniades, C. A., Παπαγεωργίου, Ν., & Stefanadis, C. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2009.00131.x · Cited by 69
“This is released extracellularly and recruits EPCs upon ischemic and apoptotic stimuli [63].”
BackgroundMeißner, M., Doll, M., Hrgović, I., Reichenbach, G., König, V., Hailemariam-Jahn, T., Gille, J., & Kaufmann, R. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.46 · Cited by 64
“VEGFR2 is only detectable at proportionally low levels in the normal adult vasculature; however, during chronic inflammation, wound repair, or tumor growth, its expression is upregulated in the involved blood vessels (Olsson et al., 2006).”
BackgroundBrain homeostasis: VEGF receptor 1 and 2—two unequal brothers in mind
Wittko-Schneider, I. M., Schneider, F. T., & Plate, K. H. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1279-3 · Cited by 62
Alghanem, A. F., Wilkinson, E. L., Emmett, M. S., Aljasir, M. A., Holmes, K., Rothermel, B. A., Simms, V. A., Heath, V. L., & Cross, M. J. (2017) · Angiogenesis · doi:10.1007/s10456-017-9542-0 · Cited by 62
Contribution of ADAM17 and related ADAMs in cardiovascular diseases
Kawai, T., Elliott, K. J., Scalia, R. G., & Eguchi, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03779-w · Cited by 64
ORIGINAL ARTICLE: Role of Regulatory and Angiogenic Cytokines in Invasion of Trophoblastic Cells
Dubinsky, V., Poehlmann, T. G., Suman, P., Gentile, T., Markert, U. R., & Gutiérrez, G. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00778.x · Cited by 62
Manetti, M., Guiducci, S., Ibba‐Manneschi, L., & Matucci‐Cerinic, M. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.05.011 · Cited by 68
“On the contrary, the specific role of VEGFR-1 in endothelial physiology is less well-defined and somewhat controversial (Olsson et al. 2006).”
BackgroundKorsisaari, N., Ross, J., Wu, X., Kowanetz, M., Pal, N., Hall, L., Eastham‐Anderson, J., Forrest, W. F., van Bruggen, N., Peale, F. V., Jr., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1552 · Cited by 62
Watanabe, M., Boyer, J. L., & Crystal, R. G. (2010) · Gene Therapy · doi:10.1038/gt.2010.87 · Cited by 64
Shi, L., Wu, T.-T., Wang, Z., Xue, J., & Xu, Y. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.008 · Cited by 64
Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs)
Monache, S. D., Angelucci, A., Sanità, P., Iorio, R., Bennato, F., Mancini, F., Gualtieri, G., & Colonna, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079309 · Cited by 62
“Given the central role played by VEGF signalling in angiogenesis [11,32,33], we tried to clarify the involvement of the VEGFR2 signalling in MF-induced anti-angiogenic effect.”
BackgroundHIF–VEGF Pathways Are Critical for Chronic Otitis Media in Junbo and Jeff Mouse Mutants
Cheeseman, M. T., Tyrer, H. E., Williams, D. J., Hough, T., Pathak, P., Romero, M. R., Hilton, H., Bali, S., Parker, A., Vizor, L., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002336 · Cited by 67
“PTK787 is an inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR-b and c-Kit; SU-11248 acts as a VEGFR2, PDGFR-b, FLT3 and c-Kit inhibitor; and BAY 43-9006 acts as a VEGFR2, FLT3, PDGFR-b, c-Kit and Raf1 inhibitor [68].”
BackgroundGuaiquil, V. H., Swendeman, S. L., Zhou, W., Guaiquil, P., Weskamp, G., Bartsch, J. W., & Blobel, C. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0591-8 · Cited by 65
“The formation of new blood vessels is critical for normal development and tissue repair, as well as for pathological events such as retinal neovascularization, rheumatoid arthritis, and tumor growth [1–6].”
BackgroundGopal, S. K., Greening, D. W., Hanssen, E. G., Zhu, H., Simpson, R. J., & Mathias, R. A. (2016) · Oncotarget · doi:10.18632/oncotarget.7573 · Cited by 62
“We anticipate that the PI3K and p38/MAPK pathways may be involved in transducing the signals for endothelial cell migration, survival, and vascular permeability [33].”
Yu, T., Guo, H., Zhou, H., Lu, J. L., Qu, Y., & Yu, D. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.175067 · Cited by 68
“The PI3K-Akt pathway is crucial for many VEGF-dependent effects, including cell survival and migration, and vasopermeability (Olsson et al., 2006).”
BackgroundCCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity
Park, M.-H., Kim, A. K., Manandhar, S., Oh, S.-Y., Jang, G.-H., Kang, L., Lee, D., Hyeon, D. Y., Lee, S.-H., Lee, H., et al. (2019) · eLife · doi:10.7554/elife.46012 · Cited by 66
“The phosphorylation of Y1054/ 1059 in the VEGFR2 kinase domain mediates kinase activity, and that of Y1175 mediates binding to the p85 subunit of PI3K and to MAPKs, which is involved in migration as well as proliferation (Olsson et al., 2006).”
BackgroundKorf‐Klingebiel, M., Reboll, M. R., Grote, K., Schleiner, H., Wang, Y., Wu, X., Klede, S., Mikhed, Y., Nobre, A., Bauersachs, J. K., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315023 · Cited by 65
Qu, Q., Pang, Y., Zhang, C., Liu, L., & Bi, Y. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01639-1 · Cited by 65
VEGFR2 alteration in Alzheimer’s disease
Cho, S.-J., Park, M. H., Han, C., Yoon, K., & Koh, Y. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-18042-1 · Cited by 61
Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
Davis, S. M., Hariharan, V. N., Lo, A. S., Turanov, A. A., Echeverria, D., Sousa, J., McHugh, N., Biscans, A., Alterman, J. F., Karumanchi, S. A., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.009 · Cited by 62
“12,13 18 Small interfering RNA (siRNA) is a promising class of drugs that bind complementary, target mRNA to reduce its expression.”
Osteoclast progenitors promote bone vascularization and osteogenesis
Kusumbe, A. P., & Adams, R. H. (2014) · Nature Medicine · doi:10.1038/nm.3747 · Cited by 67
Design, Synthesis and Biological Evaluation of Pazopanib Derivatives as Antitumor Agents
Jia, Y., Zhang, J., Feng, J., Xu, F., Pan, H., & Xu, W. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12243 · Cited by 61
“As the member of the receptor tyrosine kinase family, VEGFRs and EGFRs are the most important receptors for angiogenesis, which can initiate PI3K/AKT signaling pathways that stimulate angiogenesis (5,14).”
BackgroundFalk, T., Yue, X., Zhang, S., McCourt, A. D., Yee, B., Gonzalez, R. T., & Sherman, S. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.088 · Cited by 66
Orai1 calcium channels in the vasculature
Beech, D. J. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1090-2 · Cited by 61
“migration and endothelial remodelling events such as angiogenesis [73].”
Src Induces Podoplanin Expression to Promote Cell Migration
Shen, Y., Chen, C.-S., Ichikawa, H., & Goldberg, G. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047696 · Cited by 62
Hortelano, S., López-Fontal, R., Través, P. G., Villa, N., Grashoff, C., Boscá, L., & Luque, A. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq050 · Cited by 65
“The four endothelial lines also express the receptor tyrosine kinase VEGFR2 (Figures 2B and 3A), which mediates most of the angiogenic actions of VEGF.”
BackgroundCEACAM1: a key regulator of vascular permeability
Nouvion, A., Oubaha, M., LeBlanc, S., Davis, E. C., Jastrow, H., Kammerer, R., Breton, V., Turbide, C., Ergün, S., Gratton, J., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.073635 · Cited by 61
“VEGF promotes angiogenesis by a number of mechanisms, including stimulation of endothelial cell proliferation and migration as well as increased vascular permeability (Olsson et al., 2006).”
BackgroundCarretero-Ortega, J., Walsh, C. T., Hernández-García, R., Reyes‐Cruz, G., Brown, J. H., & Vázquez‐Prado, J. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060400 · Cited by 70
“The angiogenic properties of VEGF include the activation of signaling cascades that result in the expression of signal transduction proteins and receptors that facilitate the angiogenic response, including CXCR4 (Li et al., 2006; Olsson et al., 2006; Zheng et al., 2007).”
Chung-Yu, K., Ying-Ren, W., Lin, H.-Y., Lu, S., & Lin, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126725 · Cited by 61
Signaling pathways effecting crosstalk between cartilage and adjacent tissues
Maes, C. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.05.007 · Cited by 72
Chaudhary, A., Bag, S., Banerjee, P., & Chatterjee, J. (2019) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2019.10.002 · Cited by 65
Komabayashi‐Suzuki, M., Yamanishi, E., Watanabe, C., Okamura, M., Tabata, H., Iwai, R., Ajioka, I., Matsushita, J., Kidoya, H., Takakura, N., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.048 · Cited by 64
WOUND REPAIR: BASIC BIOLOGY TO TISSUE ENGINEERING
Clark, R. A. F., Musillo, M., & Stransky, T. (2000) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00072-1 · Cited by 64
Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature
Bolcome, R. E., Sullivan, S. E., Zeller, R., Barker, A. P., Collier, R. J., & Chan, J. C.-Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712195105 · Cited by 61
“Activation of the VEGFR2 could recruit kinases such as MAPK, AKT, and Src (50).”
InfluentialBesides adhesion: new perspectives of integrin functions in angiogenesis
Serini, G., Napione, L., Arese, M., & Bussolino, F. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn045 · Cited by 57
Endothelium as a gatekeeper of fatty acid transport
Mehrotra, D., Wu, J., Papangeli, I., & Chun, H. J. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.11.001 · Cited by 60
Wu, Q., Bai, B., Tian, C., Li, D., Yu, H., Song, B., Li, B., & Chu, X. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07181-3 · Cited by 64
“Furthermore, VEGF, once known as vascular permeability factor, could potently build up vascular permeability by increasing intracellular calcium and the production of NO, activating src kinase, and activating the Erk pathway [74, 75, 77].”
BackgroundARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling
Chen, L., Xie, X., Wang, T., Xu, L., Zhai, Z., Wu, H., Deng, L., Lu, Q., Chen, Z., Yang, X. Y., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac245 · Cited by 61
Virus interactions with endothelial cell receptors: implications for viral pathogenesis
Dalrymple, N. A., & Mackow, E. R. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.06.006 · Cited by 64
Liao, W.-X., Feng, L., Zhang, H., Zheng, J. J., Moore, T. R., & Chen, D. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0475 · Cited by 63
Notch Regulation of Tumor Angiogenesis
Bridges, E., Oon, C. E., & Harris, A. L. (2011) · Future Oncology · doi:10.2217/fon.11.20 · Cited by 65
“The VEGF receptor (VEGFR)1 (Flt1), VEGFR2 (KDR or Flk1) and VEGFR3 (Flt4) are transmembrane receptor tyrosine kinases that dimerize and become activated on ligand binding, activating signaling cascades involving ERK1/2 and AKT for example [11].”
BackgroundIqbal, U. H., Albaghdadi, H., Luo, Y. Q., Arbabi, M., Desvaux, C., Veres, T., Stanimirovic, D. B., & Abulrob, A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605937 · Cited by 60
“…the endogenous protein, vascular endothelial growth factor (VEGF), which binds to the vascular endothelial growth factor receptor 2 (VEGFR2) (Olsson et al, 2006), and Arg– Gly–Asp (RGD)containing peptides that interact with endothelial cell adhesion molecules, such as avb3 and avb5…”
BackgroundDevelopment of a two-stage limb ischemia model to better simulate human peripheral artery disease
Krishna, S. M., Omer, S. M., Li, J., Morton, S. K., Jose, R. J., & Golledge, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-60352-4 · Cited by 65
Ha, C. H., Bennett, A. M., & Jin, Z.-G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m702881200 · Cited by 60
Pin, A.-L., Houle, F., Guillonneau, M., Paquet, É. R., Simard, M. J., & Huot, J. (2012) · Angiogenesis · doi:10.1007/s10456-012-9283-z · Cited by 69
“Notably, the activation of VEGFR2 triggers the activation of several motogenic pathways including the phosphatidylinositol-3 kinase (PI3 K-Akt) pathway, the ERK pathway, the p38a and p38c pathways and the Rho GTPases and Focal Adhesion Kinase (FAK) pathways [8, 12–14].”
BackgroundA conserved role of the VEGF pathway in angiogenesis of an ectodermally-derived vasculature
Tiozzo, S., Voskoboynik, A., Brown, F. D., & Tomaso, A. W. D. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2007.12.035 · Cited by 66
“After binding of the receptor, VEGF initiates a signaling cascade that regulates the proliferation, differentiation and migration of endothelial cells (Tammela et al., 2005; Olsson et al., 2006).”
BackgroundD’Ippolito, S., Marana, R., Nicuolo, F. D., Castellani, R., Veglia, M., Stinson, J. C., Scambia, G., & Simone, N. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029660 · Cited by 59
“Growing evidence suggests that failure in the development of a functional placental vasculature, due to an imbalance between placental pro-angiogenic factors (such as VEGF) and antiangiogenic factors, leads to defective placentation and thus to severe obstetrical consequences such as recurrent pregnancy loss and preec…”
BackgroundJin, Y., Liu, Y., Lin, Q., Li, J., Druso, J. E., Antonyak, M. A., Meininger, C. J., Zhang, S. L., Dostal, D. E., Guan, J., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00650-13 · Cited by 61
Bellner, L., Martinelli, L., Halilovic, A., Patil, K., Puri, N., Dunn, M. W., Regan, R. F., & Schwartzman, M. L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158352 · Cited by 64
“Whereas VEGFR-2 and -3 have been shown to promote pathologic neovascularization (Olsson et al., 2006; Tammela et al., 2008) in vivo, their expression levels were decreased in the absence of HO-2.”
BackgroundTurley, R. S., Fontanella, A. N., Padussis, J. C., Toshimitsu, H., Tokuhisa, Y., Cho, E. H., Hanna, G., Beasley, G. M., Augustine, C. K., Dewhirst, M. W., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3000 · Cited by 57
“VEGF is a multifunctional cytokine capable of stimulating endothelial cell proliferation, migration, and survival (13).”
Nuclear FAK and its kinase activity regulate VEGFR2 transcription in angiogenesis of adult mice
Sun, S., Wu, H., & Guan, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20930-z · Cited by 60
Banerjee, S., Mehta, S., Haque, I., Sengupta, K., Dhar, K., Kambhampati, S., Veldhuizen, P. J. V., & Banerjee, S. K. (2008) · Biochemistry · doi:10.1021/bi8000352 · Cited by 59
Pan, M., Chang, T., Chang, H., Su, J.-L., Wang, H., & Hung, W.-C. (2009) · Journal of Cell Science · doi:10.1242/jcs.050005 · Cited by 64
“…signals are diminished in MP-EA.hy926 cells that are expressing K556R mutant Prox1 Recent studies have demonstrated that VEGF-C is crucial for the growth, survival, sprouting and tube formation of lymphatic endothelial cells (Makinen et al., 2001; Olsson et al., 2006; Cross et al., 2003).”
BackgroundExtracellular Vesicles Derived from Human Gingival Mesenchymal Stem Cells: A Transcriptomic Analysis
Silvestro, S., Chiricosta, L., Gugliandolo, A., Pizzicannella, J., Diomede, F., Bramanti, P., Trubiani, O., & Mazzon, E. (2020) · Genes · doi:10.3390/genes11020118 · Cited by 61
“All these proteins are crucial regulators of vascular development during embryogenesis as well as blood-vessel formation in the adult [53].”
BackgroundCannon, J. E., Upton, P., Smith, J. C., & Morrell, N. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00871.x · Cited by 58
“Dorsomorphin inhibited ERK and blocked transcription of VEGF target genes in HPAECs ERK activation is important for the angiogenic effects of VEGF signalling (Olsson et al., 2006).”
BackgroundDubey, R., Levin, M. D., Szabó, L., László, C., Kushal, S., Singh, J. B., Oh, P., Schnitzer, J. E., & Olenyuk, B. Z. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400805b · Cited by 64
Albrecht, I., Kopfstein, L., Strittmatter, K., Schomber, T., Falkevall, A., Hagberg, C. E., Lorentz, P., Jeltsch, M., Alitalo, K. K., Eriksson, U., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014109 · Cited by 60
“kinases (VEGFR-1, -2 and -3) with different specificity [2].”
BackgroundShear stress and VEGF enhance endothelial differentiation of human adipose-derived stem cells
Colazzo, F., Alrashed, F. A., Saratchandra, P., Carubelli, I., Chester, A. H., Yacoub, M. H., Taylor, P. M., & Somers, P. (2014) · Growth Factors · doi:10.3109/08977194.2014.945642 · Cited by 61
“E-mail: pamela.somers@ugent.be G ro w th F ac to rs D ow nl oa de d fr om in fo rm ah ea lth ca re .c om b y U ni ve rs ity o f N ew ca st le o n 08 /2 Fo r pe rs on al u se o nl y. of endothelial cells (Olsson et al., 2006) and subjected the cells to physiological shear stress.”
Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression
Li, D., Xie, K., Ding, G., Li, J., Chen, K., Li, H., Qian, J., Jiang, C., & Fang, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.004 · Cited by 62
Activation of the VEGFR1 Chromatin Domain
Dutta, D., Ray, S. S., Vivian, J. L., & Paul, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804349200 · Cited by 59
Csiszar, A., Sosnowska, D., Tucsek, Z., Gautam, T., Toth, P., Losonczy, G., Colman, R. J., Weindruch, R., Anderson, R. M., Sonntag, W. E., et al. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls158 · Cited by 58
“Regulation of endothelial angiogenic processes by VEGF involves activation of SAPK/JNK, Akt and p38 MAPK, and phosphorylation of HSP27 (123).”
BackgroundInfluentialSrabović, N., Mujagić, Z., Mustedanagić–Mujanović, J., Softič, A., Muminović, Z., Rifatbegović, A., & Begić, L. (2013) · International Journal of Breast Cancer · doi:10.1155/2013/746749 · Cited by 58
Huang, M., Qiu, Q., Xiao, Y., Zeng, S., Zhan, M., Shi, M., Zou, Y., Ye, Y., Liang, L., Yang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep23770 · Cited by 64
Xie, J., Liu, J., Liu, H., Liao, X., Chen, Y., Lin, M.-G., Gu, Y.-Y., Liu, T., Wang, D., Ge, H., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2921-x · Cited by 61
“ligands and modulated by a variety of biological processes including dimerization, internalization, degradation, and receptor presentation [22, 23].”
Zhang, J., Neoh, K. G., & Kang, E. T. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2441 · Cited by 58
Zhang, X.-N., Ma, Z.-J., Wang, Y., Sun, B., Guo, X., Pan, C., & Chen, L.-M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177862 · Cited by 52
High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation
Jin, F., Hagemann, N., Sun, L., Wu, J., Doeppner, T. R., Dai, Y., & Hermann, D. M. (2018) · Angiogenesis · doi:10.1007/s10456-018-9603-z · Cited by 58
“Since VEGFR2 is activated via tyrosine phosphorylation [24], phosphorylations of VEGFR2 at Tyr1175 and Tyr1054/1059 residues were examined.”
BackgroundŞahin, S., Çağlayan, M. O., & Üstündağ, Z. (2020) · Microchimica Acta · doi:10.1007/s00604-020-04526-x · Cited by 58
Jakobsson, L., Domogatskaya, A., Tryggvason, K., Edgar, D., & Claesson‐Welsh, L. (2008) · The FASEB Journal · doi:10.1096/fj.07-9617com · Cited by 54
“Angiogenesis is initiated by vascular endothelial growth factor (VEGF), which activates vascular endothelial growth factor receptor 2 (VEGFR-2) on the EC ( 1 ).”
BackgroundCDP-diacylglycerol, a critical intermediate in lipid metabolism
Jennings, W., & Epand, R. M. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104914 · Cited by 58
Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies
Hsu, P.-Y., Mammadova, A., Benkirane-Jessel, N., Désaubry, L., & Nebigil, C. G. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.694711 · Cited by 58
“VEGF signaling promotes production of NO and the vasodilatory prostanoid prostacyclin (PGI2) through activation of phospholipase A2 via PLCγ/PKC pathways (23).”
BackgroundFAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer
Shiau, J., Wu, C.-C., Chang, S., Pan, M., Liu, W., Ou‐Yang, F., Chen, F., Hou, M., Shih, S., & Luo, C. (2021) · Biomedicines · doi:10.3390/biomedicines9121789 · Cited by 57
New radiotracers for imaging of vascular targets in angiogenesis-related diseases
Hong, H., Chen, F., Zhang, Y., & Cai, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.011 · Cited by 58
“Numerous studies have been performed to identify the roles in angiogenesis of various molecule families including VEGFs and their receptors (VEGFRs) [18,19], Tie receptors [20], integrins [21], other growth factor receptors [22–24], as well as various cell adhesion”
к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling
Yamamizu, K., Furuta, S., Hamada, Y., Yamashita, A., Kuzumaki, N., Narita, M., Doi, K., Katayama, S., Nagase, H., Yamashita, J. K., et al. (2013) · Scientific Reports · doi:10.1038/srep03213 · Cited by 59
Angiogenesis in Diabetic Nephropathy
Zent, R., & Pozzi, A. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.007 · Cited by 63
Chamorro-Jorganes, A., Araldi, E., Rotllan, N., Cirera-Salinas, D., & Suárez, Y. (2014) · Journal of Cell Science · doi:10.1242/jcs.130518 · Cited by 57
“Their pro-angiogenic effects are mediated through VEGF receptor 2 (VEGFR2) (Cross and Claesson-Welsh, 2001; Olsson et al., 2006; Presta et al., 2005) or FGF receptor 1 (FGFR1) (Cross and Claesson-Welsh, 2001; Olsson et al., 2006; Presta et al., 2005), respectively.”
BackgroundInfluentialEvidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis
Salvati, E., Zizza, P., Rizzo, A., Iachettini, S., Cingolani, C., D’Angelo, C., Porru, M., Randazzo, A., Pagano, B., Novellino, E., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1289 · Cited by 64
Roberts, O. L., Holmes, K., Müller, J., Cross, D. A. E., & Cross, M. J. (2010) · Journal of Cell Science · doi:10.1242/jcs.072801 · Cited by 66
“VEGF receptor1 (VEGFR-1/Flt-1) and VEGFR-2 (Flk-1/KDR) are present on vascular endothelial cells, whereas expression of VEGFR-3 (Flk-4) is confined to lymphatic endothelial cells (Cross et al., 2003; Lohela et al., 2009; Olsson et al., 2006).”
BackgroundSaha, S., Islam, M. K., Shilpi, J. A., & Hasan, S. (2013) · In Silico Pharmacology · doi:10.1186/2193-9616-1-11 · Cited by 62
“In combination with chemotherapy, Bevacizumab prolongs the survival rate of patients with solid tumor (Olsson et al., 2006).”
BackgroundInfluentialMayer, E. L., Dallabrida, S. M., Rupnick, M. A., Redline, W., Hannagan, K., Ismail, N. S., Burstein, H. J., & Beckman, J. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168120 · Cited by 57
Ordinary and Activated Bone Grafts: Applied Classification and the Main Features
Deev, R. V., Drobyshev, A. Y., Bozo, I. Y., & Isaev, A. A. (2015) · BioMed Research International · doi:10.1155/2015/365050 · Cited by 61
“Moreover, axis PI3K/AKT along with calcium ions modulate the activity of endothelial NO-synthase, which is accompanied by a rise in NO production and an increase in vascular permeability, which leads to angiogenesis (Figure 3) [95, 96].”
Jung, J. I., Kim, E. J., Kwon, G. T., Jung, Y. J., Park, T., Kim, Y., Yu, R., Choi, M., Chun, H. S., Kwon, S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv076 · Cited by 63
Hao, D., Xiao, W., Liu, R., Kumar, P., Li, Y., Zhou, P., Guo, F., Farmer, D. L., Lam, K. S., Wang, F., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00118 · Cited by 58
Ghorbanzadeh, V., Mohammadi, M., Dariushnejad, H., Abhari, A., Chodari, L., & Mohaddes, G. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170087 · Cited by 62
Troncoso, F., Acurio, J., Herlitz, K., Aguayo, C. R., Bertoglia, P., Guzmán‐Gutiérrez, E., Loyola, M., González, M., Rezgaoui, M., Desoyé, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182509 · Cited by 61
Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
Sui, Y.-B., Wang, Y., Liu, L., Liu, F., & Zhang, Y. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1569697 · Cited by 57
“Vascular endothelial growth factor (VEGF) is a crucial regulator of angiogenesis, which is produced by cells and can stimulate the formation of blood vessels (Ferrara et al. 2003; Olsson et al. 2006).”
BackgroundSmith, N. R., James, N. H., Oakley, I., Wainwright, A., Copley, C. G., Kendrew, J., Womersley, L., Jürgensmeier, J. M., Wedge, S. R., & Barry, S. T. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0142 · Cited by 58
Falk, T., Gonzalez, R. T., & Sherman, S. J. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11082875 · Cited by 60
“Further complicating the picture is that with VEGFR1 binding of its different ligands VEGF-A, VEGF-B and PLGF transduces distinct biological responses, and leads to different phosphorylation patterns [36].”
BackgroundLi, W., Fraser, J. L., Yu, S. P., Zhu, J., Jiang, Y., & Wei, L. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2849-y · Cited by 57
Preeclampsia and Soluble fms-Like Tyrosine Kinase 1
Roberts, J. M., & Rajakumar, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0945 · Cited by 63
“The growth factor VEGF functions to stimulate angiogenesis and to maintain endothelial integrity especially in a fenestrated endothelium as is present in the glomerular capillaries (4).”
BackgroundThe VEGF Family, the Inside Story
Heloterä, H., & Alitalo, K. K. (2007) · Cell · doi:10.1016/j.cell.2007.08.012 · Cited by 56
“Lee et al. report that exogenous VEGF is unable to compensate for the loss of endogenous VEGF in endothelial cells, despite the fact that signaling through VEGFR2 activates several downstream pathways, including the PI3K/AKT pathway responsible for cell survival (Olsson et al., 2006).”
BackgroundNatural products targeting tumour angiogenesis
Lu, X., Friedrich, L. J., & Efferth, T. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16232 · Cited by 61
“Particularly, vascular endothelial growth factors (VEGFs) and their membrane receptors ( VEGFRs ) are of great importance during tumour-induced angiogenesis (Olsson et al., 2006).”
VEGF‐A expression in osteoclasts is regulated by NF‐κB induction of HIF‐1α
Trebec‐Reynolds, D. P., Voronov, I., Heersche, J. N. M., & Manolson, M. F. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22542 · Cited by 57
“VEGFs are a family of growth factors involved in angiogenesis/ vasculogenesis and lymphangiogenesis [Olsson et al., 2006].”
BackgroundChappell, J. C., Mouillesseaux, K. P., & Bautch, V. L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301805 · Cited by 66
“Binding of VEGF-A to the tyrosine kinase receptor Flk-1 (VEGF receptor-2) initiates signaling in endothelial cells to promote migration, proliferation, and survival.(6) Flt-1 (VEGF receptor-1) binds VEGF-A with 10-fold higher affinity than Flk-1 but acts primarily as a ligand sink, limiting the amount of VEGF-A that c…”
BackgroundNogo-B receptor is essential for angiogenesis in zebrafish via Akt pathway
Zhao, B., Chun, C., Liu, Z., Horswill, M. A., Pramanik, K., Wilkinson, G. A., Ramchandran, R., & Miao, Q. (2010) · Blood · doi:10.1182/blood-2010-02-271577 · Cited by 57
MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs
Zomorrod, M. S., Hajifathali, A., Kouhkan, F., Mehdizadeh, M., Rad, S. M. A. H., & Soleimani, M. (2016) · Tumor Biology · doi:10.1007/s13277-016-4845-0 · Cited by 59
“Among these factors, VEGF and FGF are probably the most critical and dominant factors [5, 6].”
Background
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.